1. Emerging, noninvasive surrogate markers of atherosclerosis
- Author
-
Marshall D. Goldin, Rachel Neems, Samir N. Patel, Charlotte Bai, Sanjay Pandya, Benjamin M. Fiedler, Venkataraman Rajaram, Matthew J. Feinstein, and Steven B. Feinstein
- Subjects
Diagnostic Imaging ,medicine.medical_specialty ,Brachial Artery ,Arteriosclerosis ,Magnetic resonance angiography ,Coronary circulation ,Cardiac magnetic resonance imaging ,Coronary Circulation ,Internal medicine ,medicine.artery ,medicine ,Medical imaging ,Humans ,Brachial artery ,Angiology ,Clinical Trials as Topic ,medicine.diagnostic_test ,business.industry ,Coronary flow reserve ,Carotid Arteries ,medicine.anatomical_structure ,Cardiovascular Diseases ,Echocardiography ,Cardiology ,Radiology ,Tomography, X-Ray Computed ,Tunica Intima ,Tunica Media ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Blood Flow Velocity ,Magnetic Resonance Angiography ,Reactivity Testing - Abstract
Noninvasive surrogate markers of atherosclerosis allow the physician to identify subclinical disease before the occurrence of adverse cardiovascular events, thereby limiting the need to perform invasive diagnostic procedures. Imaging modalities, such as carotid artery ultrasound, two-dimensional echocardiography, coronary artery calcium imaging, cardiac magnetic resonance imaging, ankle-brachial indices, brachial artery reactivity testing, and epicardial coronary flow reserve measurements, provide information that may improve the predictive value of a person's risk of developing clinically significant atherosclerotic disease. Newer imaging modalities have also emerged to bring insight into the pathophysiology and treatment of atherosclerosis.
- Published
- 2004
- Full Text
- View/download PDF